University/Organization: University of Cambridge
Country: United Kingdom
Professor Dr. Sorush Niknamian holds Ph.D. in Cellular and Molecular Biology, B.Sc. in Mechatronics Engineering, B.Sc. in Applied Mathematics, He is a CSci (Chartered Scientist), RSciTech (Registered Science Technician), RSci (Registered Scientist) and Science Council, United Kingdom and Indiana Cancer Consortium (ICC) certified. He is the Board member of Weston A. Price Foundation in Washington, United States, Member of American Association for Cancer Research (AACR), Ambassador of European Association for Cancer Research (EACR), Member of Federal Health Professionals in the United States Marine Forces, Army Forces and Military Medicine, Registered Researcher in the U.S. Government's System for Award Management (NAS) and certified member of Royal Society of Biology (MRSB). He has been published 27 books in medical and biological sciences including Medicine, Nutrition, Cancer Prevention and Treatment. He has published 30 research articles in international high impact journals in many fields of medicine. He has been working on cancer treatment, Cause and Prevention alongside Professor Thomas N. Seyfried, Professor Stephanie Seneff, Professor Domonic D’Agostino and Miriam Kalamian. He has hypothesized cancer as an Evolutionar Metabolic Disease (Disorder) and introduced a new protocol in the treatment of cancer which has been supported by Boston University, Massachusetts Institute of Technology, South Florida University, Puerto Rico Medical University and Harvard University. He is a Professional Reviewer, Peer-Review Corp and Editorial Board at National Institute for Health Research (NIHR), Editor of the Publishing Research Group, American Society of Clinical Oncology (ASCO), Member of peer review corps at Journal of Clinical Oncology (JCO), JCO Clinical Cancer Informatics, JCO Precision Oncology, Journal of Oncology Practice, Dove Medical Press (Adolescent Health, Medicine and Therapeutics Journal), Dove Medical Press. (Biologics: Targets and Therapy Journal) and Dove Medical Press (Cancer Management and Research) and etc. He is the Guest editor of Nature Medicine Journal and the editorial Board Member of Global Access Publishers (Global Journal of Neurology). He is a Nominee of many international awards including Nobel Prize in 2017 and Edison Award 2019.
His research interests includes: Breast Cancer; Cancer Biology; Cancer Cell Biology; Cancer Research; HIV/Aids; Lung Cancer; Medical Biochemistry and Metabolomics; Metabolic Medicine; Multiple Sclerosis; Neuroscience; Oncology; Oncology and Carcinogenesis; Prostate Cancer
Scientia Ricerca is licensed and content of this site is available under a Creative Commons Attribution 4.0 International License.